Compare CMPX & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMPX | UTL |
|---|---|---|
| Founded | 2014 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 927.5M | 906.9M |
| IPO Year | 2020 | 1995 |
| Metric | CMPX | UTL |
|---|---|---|
| Price | $1.90 | $50.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $14.57 | ★ $56.50 |
| AVG Volume (30 Days) | ★ 12.0M | 83.5K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 3.65% |
| EPS Growth | N/A | ★ 1.37 |
| EPS | N/A | ★ 1.85 |
| Revenue | N/A | ★ $536,000,000.00 |
| Revenue This Year | N/A | $5.43 |
| Revenue Next Year | $934.41 | $4.22 |
| P/E Ratio | ★ N/A | $27.45 |
| Revenue Growth | N/A | ★ 8.33 |
| 52 Week Low | $1.61 | $45.11 |
| 52 Week High | $6.88 | $55.34 |
| Indicator | CMPX | UTL |
|---|---|---|
| Relative Strength Index (RSI) | 27.05 | 40.37 |
| Support Level | $1.61 | $49.33 |
| Resistance Level | $3.54 | $50.77 |
| Average True Range (ATR) | 0.17 | 1.28 |
| MACD | 0.05 | -0.10 |
| Stochastic Oscillator | 47.22 | 26.58 |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Unitil Corp through its subsidiaries engages in the distribution of electricity and natural gas in its service territories in the states of New Hampshire, Massachusetts and Maine. Its natural gas operations include gas distribution utility operations and interstate gas transmission pipeline operations. It also engages in interstate natural gas transmission pipeline company, operating approximately 85 miles of underground gas transmission pipeline located in Maine and New Hampshire. The company's segments include Electric and Gas.